Vanguard Group’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-1,503,258
| Closed | -$706K | – | 4171 |
|
|
2016
Q1 | $706K | Buy |
1,503,258
+25,720
| +2% | +$12.1K | ﹤0.01% | 3695 |
|
|
2015
Q4 | $1.01M | Buy |
1,477,538
+40,374
| +3% | +$27.5K | ﹤0.01% | 3627 |
|
|
2015
Q3 | $1.4M | Buy |
1,437,164
+38,946
| +3% | +$37.8K | ﹤0.01% | 3528 |
|
|
2015
Q2 | $1.68M | Buy |
1,398,218
+53,115
| +4% | +$63.7K | ﹤0.01% | 3479 |
|
|
2015
Q1 | $1.43M | Buy |
1,345,103
+47,156
| +4% | +$50K | ﹤0.01% | 3530 |
|
|
2014
Q4 | $1.41M | Buy |
1,297,947
+12,736
| +1% | +$13.9K | ﹤0.01% | 3410 |
|
|
2014
Q3 | $1.39M | Buy |
1,285,211
+37,396
| +3% | +$40.4K | ﹤0.01% | 3409 |
|
|
2014
Q2 | $1.3M | Sell |
1,247,815
-46,538
| -4% | -$48.4K | ﹤0.01% | 3416 |
|
|
2014
Q1 | $1.33M | Buy |
1,294,353
+22,188
| +2% | +$22.9K | ﹤0.01% | 3363 |
|
|
2013
Q4 | $1.48M | Sell |
1,272,165
-178,709
| -12% | -$207K | ﹤0.01% | 3309 |
|
|
2013
Q3 | $2.44M | Sell |
1,450,874
-331,883
| -19% | -$557K | ﹤0.01% | 3057 |
|
|
2013
Q2 | $3.57M | Buy |
+1,782,757
| New | +$3.57M | ﹤0.01% | 2847 |
|